pcDNA3.1 NL Citations (2)

Originally described in: LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells.
Trepte P, Kruse S, Kostova S, Hoffmann S, Buntru A, Tempelmeier A, Secker C, Diez L, Schulz A, Klockmeier K, Zenkner M, Golusik S, Rau K, Schnoegl S, Garner CC, Wanker EE Mol Syst Biol. 2018 Jul 11;14(7):e8071. doi: 10.15252/msb.20178071. PubMed Journal

---

Articles Citing pcDNA3.1 NL

Articles
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor. Trepte P, Secker C, Olivet J, Blavier J, Kostova S, Maseko SB, Minia I, Silva Ramos E, Cassonnet P, Golusik S, Zenkner M, Beetz S, Liebich MJ, Scharek N, Schutz A, Sperling M, Lisurek M, Wang Y, Spirohn K, Hao T, Calderwood MA, Hill DE, Landthaler M, Choi SG, Twizere JC, Vidal M, Wanker EE. Mol Syst Biol. 2024 Apr;20(4):428-457. doi: 10.1038/s44320-024-00019-8. Epub 2024 Mar 11. PubMed
A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in mice. Brenner D, Sieverding K, Srinidhi J, Zellner S, Secker C, Yilmaz R, Dyckow J, Amr S, Ponomarenko A, Tunaboylu E, Douahem Y, Schlag JS, Rodriguez Martinez L, Kislinger G, Niemann C, Nalbach K, Ruf WP, Uhl J, Hollenbeck J, Schirmer L, Catanese A, Lobsiger CS, Danzer KM, Yilmazer-Hanke D, Munch C, Koch P, Freischmidt A, Fetting M, Behrends C, Parlato R, Weishaupt JH. J Exp Med. 2024 May 6;221(5):e20221190. doi: 10.1084/jem.20221190. Epub 2024 Mar 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.